期刊文献+

RNA干扰瞬时受体电位阳离子通道1表达抑制缺氧诱导的胶质瘤血管内皮生长因子上调的实验研究

Experimental study on down-regulation of TRPC1 inhibits expression of VEGF induced by hypoxia in glioma cells
下载PDF
导出
摘要 目的探讨瞬时受体电位阳离子通道1(TRPC1)是否参与缺氧诱导的胶质瘤细胞血管内皮生长因子(VEGF)表达。方法通过RT-PCR和钙图检测技术观察U87细胞上表达的TRPC亚型;采用RNAi技术、real-time RT-PCR、免疫印迹和ELISA方法,在基因和外分泌蛋白水平观察TRPC1对缺氧U87细胞VEGF表达的影响。结果 U87胶质瘤细胞表达TRPC1,TRPC3,TRPC4和TRPC5亚型。TRPC通道激动剂OAG增加了胞内Ca2+浓度,而TRPC通道阻断剂2-APB可抑制激动剂诱导的胞内Ca2+浓度增加。化学合成的siRNA-1,siRNA-2和siRNA-3分别减少TRPC1 mRNA到64%,39%和36%(P<0.01);分别减少TRPC1蛋白到48%,29%和33%(P<0.01)。siRNA-2和siRNA-3显著抑制了缺氧诱导的VEGF基因上调(P<0.01)。同时缺氧U87细胞VEGF蛋白的分泌亦受到抑制(P<0.01)。结论 U87胶质瘤细胞表达功能性的TRPC通道,TRPC1参与缺氧诱导的胶质瘤VEGF表达。 Objective To investigate whether TRPC1 was involved in VEGF expression induced by hypoxia in U87 MG cells. Methods RT-PCR and calcium image technique were used to observe the TRPC subtypes existed in U87 cells. RNAi, real-time RT-PCR, western blot and ELISA technique were used to observe effects of TRPC1 on hypoxia- induced VEGF gene expression and secretion. Results TRPC1, TRPC3, TRPC4 and TRPC5 were found expressed in U87 cell. Calcium concentration of U-87 cells was increased by OAG (agonist of TRPC), OAG-induced calcium con- centration rise was attenuated by 2-APB (antagonist of TRPC). TRPC1 mRNA were reduced to 64%, 39% and 36% respectively by the chemical synthesis of siRNA-1, siRNA-2, siRNA-3 (P 〈 0.01); TRPC1 protein were reduced to 48%, 29%, 33% respectively by the chemical synthesis of siRNA-1, siRNA-2, siRNA-3 (P 〈 0.01). Hypoxia en- hanced VEGF gene up-regulation was restrained by siRNA-2 and siRNA-3 (P 〈 0.01); VEGF gene expression in Hypoxia U87 cell was restrained too (P 〈 0,01). Conclusion U87 glioma cells express the functional TRPC channels; TRPC1 participates the VEGF expression induced by hypoxia.
出处 《中国医药导报》 CAS 2013年第16期4-6,9,共4页 China Medical Herald
基金 广东省高校优秀青年创新人才培育项目(编号:LYM09040) 国家自然科学基金资助项目(编号:81101611)
关键词 神经胶质瘤 缺氧 瞬时受体电位阳离子通道1 血管内皮生长因子 Glioblastoma Hypoxia TRPC1 channel VEGF
  • 相关文献

参考文献3

二级参考文献69

  • 1骆晓梅,刘家云,苏明权,郝晓柯.肿瘤特异性survivin启动子在前列腺癌细胞中的活性鉴定[J].中华男科学杂志,2007,13(6):502-506. 被引量:5
  • 2Semenza GL.Signal transduction to hypoxia-inducible factor[J].Biochem Pharmaco,2002,64(5-6):993-998.
  • 3Shi H.Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke[J].Curr Med Chem,2009,16(34):4593-4600.
  • 4Smith TG,Talbot NP.Prolyl hydroxylases and therapeutics[J].Antioxid Redox Signal,2010,12(4):431-433.
  • 5Gora Kupilas K,Josko J.The neuroprotective function of vascular endothelial growth factor (VEGF)[J].Folia Neuropathol,2005,43(1):31-39.
  • 6Jurasz P,Yurkova N,Kirshenbaum L,et al.VEGF masks BNIP3-mediated apoptosis of hypoxic endothelial cells [J].Angiogenesis,2011,14(2):199-207.
  • 7Karsten R,Dorette F,Maria K,et al.Erythropoietin is a paracrine mediator of ischemia tolerance in the brain: evidence from an in vitro model[J].J Neurosci,2002,22(23):10291-10301.
  • 8Ehrenreich H,Hasselblatt M,Dembowski C,et al.Erythropoietin therapy for acute stroke is both safe and beneficial[J].Mol Med,2002,8(8):495-505.
  • 9Semenza GL.HIF-1:upstream anddownstream of cancer metabolism[J].Curr Opin Genet Dev,2010,20(1):51-56.
  • 10Helton R,Cui J,Scheel JR,et al.Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage[J]. J Neurosci, 2005, 25 (16):4099-40107.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部